Get In Touch
Allegory Capital SA,
Rue du Sablon 2
1110 Morges
Switzerland
+41 21 561 34 97
contact-ch@allegory.capital
Work Inquiries
work@allegory.capital
+41 21 561 34 97
Back

Venture capital

A row of unbranded GLP-1 autoinjector pens on a polished steel surface in a clean pharmaceutical setting
  • Orsen Okami
  • Posted by Orsen Okami
June 23, 2026

The GLP-1 Endgame: Value Is Migrating Off the Molecule

Lilly catches Novo, Ypsomed sells diabetes care, Virta cuts GLP-1 use, WeightWatchers files Chapter 11. Where the next decade of obesity-care value sits.

Read More
  • Orsen Okami
  • Posted by Orsen Okami
June 12, 2026

Oncology's Data Gold Rush: The Asset Is the Patient Data

In 2025 pharma majors moved from buying AI to building it on someone else's data. Tempus and ConcertAI showed the asset in oncology AI is the patient data.

Read More
  • Orsen Okami
  • Posted by Orsen Okami
December 31, 2025

The AI Adoption Challenge: Go Beyond the Shiny Object in 2026

After a decade of digital transformation consulting and supporting brands through emerging technology adoption, 2025 revealed the hardest truth about AI implementation: technology was never the bottleneck. People and culture were.

Read More
Michele Mattei
  • Orsen Okami
  • Posted by Orsen Okami
December 30, 2025

How a Venture Partner Drives Fintech Innovation: An Interview with Michele Mattei of Allegory Capital

At Allegory Capital, the venture partner model occupies a central position. Michele Mattei, a fintech professional with a background spanning digital banking, accelerators and angel investing, exemplifies how this hybrid role translates market knowledge into portfolio value.

Read More
Businesswoman has group call via zoom. Online meeting and business development on quarantine.
  • Orsen Okami
  • Posted by Orsen Okami
August 13, 2025

How to Lead Investor Meetings Like a Pro: The Structure That Converts Interest into Commitment

The Moment That Separates Pretenders From Performers¹ You’ve rehearsed your pitch deck...

Read More
Building of the Council of Europe in Strasbourg
  • Orsen Okami
  • Posted by Orsen Okami
July 25, 2025

European Venture Capital Performance Holds Strong—But for How Long?

Europe’s venture capital stays ahead with rising valuations and dry powder, but liquidity challenges threaten its lead as US exits regain pace.

Read More
Building of the Council of Europe in Strasbourg
  • Haider Alleg
  • Posted by Haider Alleg
March 11, 2025

Europe’s Startup Support Machine: How Incubators and Accelerators Work?

The European Startup Ecosystem: Growth, Funding, and the Long-Term Dilemma Europe’s startup...

Read More
  • Haider Alleg
  • Posted by Haider Alleg
September 10, 2020

Raising Venture Capital

Friends or family When you start raising money for your company, one...

Read More